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ABSTRACT
Speciﬁc amino acids are now known to acutely and chronically regulate insulin secretion from
pancreaticβ-cellsinvivoandinvitro.Understandingthemolecularmechanismsbywhichaminoacids
regulate insulin secretion may identify novel targets for future diabetes therapies. Mitochondrial
metabolism is crucial for the coupling of amino acid and glucose recognition to the exocytosis of
the insulin granules. This is illustrated by in vitro and in vivo observations discussed in the present
review. Mitochondria generate ATP, which is the main coupling factor in insulin secretion; however,
the subsequent Ca2+ signal in the cytosol is necessary, but not sufﬁcient, for full development of
sustained insulin secretion. Hence mitochondria generate ATP and other coupling factors serving
as fuel sensors for the control of the exocytotic process. Numerous studies have sought to identify
the factors that mediate the amplifying pathway over the Ca2+ signal in nutrient-stimulated insulin
secretion. Predominantly, these factors are nucleotides (GTP, ATP, cAMP and NADPH), although
metabolites have also been proposed, such as long-chain acyl-CoA derivatives and the key amino
acidglutamate.Thisscenariohighlightsfurthertheimportanceofthekeyenzymesortransporters,
glutamate dehydrogenase, the aspartate and alanine aminotransferases and the malate/aspartate
shuttle, in the control of insulin secretion. Therefore amino acids may play a direct or indirect (via
generation of putative messengers of mitochondrial origin) role in insulin secretion.
INTRODUCTION
Amino acid metabolism, under appropriate conditions,
is known to enhance insulin secretion from primary islet
cells and β-cell lines [1–5]. In vivo, l-glutamine and l-
alanine are quantitatively the most abundant amino acids
in the blood and extracellular ﬂuids followed closely by
the branched-chain amino acids [6]. The positive effect of
two amino acids, leucine plus phenylalanine, on insulin
secretion was reported in a recent clinical assessment
of the effect of leucine and phenylalanine administered
inthepresenceofaproteinhydrolysatetoTypeIIdiabetic
patients and suitable controls, which resulted in a 3-fold
increase in insulin secretion compared with carbohydrate
alone [7]. As in vivo insulin secretion is normally
determined by administration of an oral or intravenous
glucose load, it is probable that in vivo insulin secretion
measurements are an underestimate of that possible from
a mixed nutritional load. From in vitro studies, l-alanine
metabolism is known to enhance insulin secretion alone
or synergistically enhance glucose-stimulated insulin
secretion from the clonal β-cell line BRIN-BD11 [8,9];
however, l-glutamine, although readily consumed by β-
cells,doesnotstimulateinsulinsecretionintheabsenceof
allosteric activation of GDH (glutamate dehydrogenase).
l-Leucine may enhance l-glutamine-stimulated insulin
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Figure 1 Model for the regulation of insulin secretion in the β-cell stimulated by glucose and amino acids
Glucose equilibrates across the plasma membrane and is phosphorylated by glucokinase (GK). Glycolysis produces pyruvate (Pyr) that enters the mitochondria and is a
substrate both for pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC). Mitochondrial metabolism is also activated by amino acids such as alanine, glutamine,
or glutamate. The TCA cycle generates reducing equivalents (red. equ.), which are transferred to the electron transport chain, leading to hyperpolarization of the
mitochondrial membrane (  m) and generation of ATP. ATP is then transferred to the cytosol, raising the ATP/ADP ratio. Subsequently, closure of KATP-channels
depolarizes the cell membrane (  c). This opens voltage-dependent Ca2+ channels, increasing cytosolic Ca2+ concentration ([Ca2+]c), which triggers insulin
exocytosis.
secretion by acting as a GDH allosteric activator [10].
Alternatively, in islets overexpressing GDH, glutamine
enhances both mitochondrial metabolism and insulin
secretion [11]. Although many investigators have used
high concentrations of individual amino acids in vitro,a
study by Bolea et al. [12] has demonstrated that speciﬁc
amino acid mixtures at physiological concentrations
potently stimulate insulin secretion. Four amino acids
were found to be particularly important for stimulating
β-cell electrical activity, essential for insulin secretion:
leucine, isoleucine, alanine and arginine.
Thusarelativelysmallnumberofaminoacidspromote
or synergistically enhance insulin release from pancreatic
β-cells [13,14]. The mechanisms by which amino acids
enhance insulin secretion are varied. The cationically
charged amino acid l-arginine does so by direct depo-
larization of the plasma membrane at neutral pH, but
onlyinthepresenceofglucose.Otheraminoacids,which
are co-transported with Na+, can also depolarize the cell
membrane as a consequence of Na+ transport and thus
induce insulin secretion by activating voltage-dependent
Ca2+ channels. Metabolism of amino acids, resulting
in partial oxidation, e.g. l-alanine [8], may initially
increase the cellular content of ATP, leading to closure
of the ATP-sensitive K+ channel, depolarization of the
plasma membrane, activation of voltage-activated Ca2+
channels, Ca2+ inﬂux and insulin exocytosis. However,
it is possible to additionally stimulate insulin secretion
via allosteric effects on regulatory proteins such as GDH
(as described for leucine) [15]. In general, metabolism of
key amino acids appears to be necessary for appropriate
generation of regulatory ‘signals’ which then impact
upon insulin secretion. The identity of these regulatory
signals has remained elusive, but evidence suggests that
mitochondrialsignalsareimportant,includinggeneration
of ATP, citrate and glutamate [16]. The potential roles of
some key amino acids in the pancreatic β-cell are sum-
m a r i z e di nF i g u r e1 .
STIMULUS–SECRETION COUPLING
CIRCUITRY IN THE β-CELL
Invivo,theβ-cellisconstantlymonitoringnutrientavail-
ability and metabolic status and can generate appropriate
secondary stimulus-coupling signals in response to the
mostminorchangesintheconcentrationofspeciﬁcmeta-
bolites. This is coupled with regulatory input from other
signalling pathways, including neuropeptides. The β-cell
ismetabolicallydistinctfromalmostallothermammalian
cell types in several respects: (i) it can utilize glucose
in the physiologically relevant range (2–20 mM) as it
expresses a combination of GLUT-2 (high Km glucose
transporter) and glucokinase, (ii) it possesses low lactate
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dehydrogenaseandplasmamembranemono-carboxylate
pyruvate/lactatetransporteractivityandcorrespondingly
high activity in the mitochondrial malate/aspartate
shuttle, so ensuring mitochondrial oxidation of NADH,
(iii) it has a high activity of both pyruvate dehydrogenase
and pyruvate carboxylase, ensuring that anaplerotic and
oxidative metabolism of glucose/pyruvate can co-exist.
All these speciﬁc metabolic adaptations are geared to
enhancing mitochondrial TCA (tricarboxylic acid) cycle
activity, oxidative phosphorylation and efﬁcient ATP
production. An enhancement of the ATP/ADP ratio
results in closure of the ATP-sensitive K+ channel, de-
polarizationoftheplasmamembrane,openingofvoltage-
activated Ca2+ channels, inﬂux of Ca2+ and ﬁnally fusion
of insulin-containing granules with the plasma mem-
brane. The opening of Ca2+ channels is intermittent,
oscillating with the membrane potential, and therefore
results in oscillations of [Ca2+]i (intracellular Ca2+ con-
centration) that, in turn, trigger oscillations of insulin
secretion [17].
In addition to this metabolic complexity, the β-cell
can metabolize a number of key amino acids which,
via mitochondrial metabolism, can generate further sti-
mulus–secretion ‘coupling’ factors. Lipid metabolism,
via long-chain acyl-CoA formation, may also impact
upon insulin secretion [18]. Indeed, it was reported that
citrate exported from the mitochondria to the cyto-
sol forms malonyl-CoA with CoA, promoting the
accumulation of long-chain acyl-CoAs [19], thereby
enhancing Ca2+-evoked insulin exocytosis [18]. Amino
acids also play a role as modulators of lipid metabolism.
Acetyl-CoA carboxylase, responsible for malonyl-CoA
synthesis, is activated by glutamate-sensitive PP2A
(protein phosphatase 2A) [20], an effect demonstrated
in islet β-cells [21]. Recently, we have demonstrated that
addition of 10 mM l-alanine to the BRIN-BD11 β-cell
line increased expression of ATP-citrate lyase by 2-fold
(G. A. Cunningham, N. H. McClenaghan, P. R. Flatt
andP.Newsholme,unpublishedwork).ATPcitratelyase
will convert citrate into acetyl-CoA in the cytosol, thus
providingthekeystepinfattyacidsynthesis,acetyl-CoA
carboxylase, with substrate.
In the mitochondrial matrix, Ca2+ increases the
activity of several dehydrogenases. In this manner, in-
creased cytosolic Ca2+ occurring during cell activation
is relayed to the mitochondria via a Ca2+ uniporter
[22]. Such Ca2+ entry is favoured by activation of the
respiratory chain, for instance by glucose in the β-
cell. Therefore hyperpolarization of the mitochondrial
membrane permits the rise in mitochondrial Ca2+ further
activating NADH-generating dehydrogenases [23]. The
primary actions of glucose are via potentiation of ATP
concentration by enhanced TCA cycle substrate (oxi-
dative and anaplerotic) supply. Generation of other
additive factors derived from glucose metabolism might
also be promoted by mitochondrial Ca2+ elevation [24].
SIGNALLING ROLE OF AMINO ACIDS
Certain amino acids are now known to play important
nutrient-sensing roles involving the mTOR (mammalian
target of rapamycin)-mediated signalling pathway [25].
mTOR is a component of a signalling pathway which
couplesinsulinreceptorstimulationandnutrientavailab-
ilitywithproteinsynthesisviaactivationandphosphoryl-
ation of the ribosomal protein S6. This is accomplished
via activation of the protein kinase p70S6K, which is
sensitive to both mTOR and insulin signalling pathways.
Leucine is the most effective amino acid in this regard.
The activation of the mTOR pathway is probably
important in the β-cell where mTOR and insulin signal-
ling are likely to synergize to stimulate both protein
synthesis and insulin secretion [26,27]. It is not known
how amino acids activate mTOR, but it is probable that
stimulationofakinaseorinhibitionofaphosphatasethat
act upon mTOR as a substrate is involved [25,28].
EFFECT OF AMINO ACIDS ON GENE
EXPRESSION IN THE β-CELL
Although glucose and fatty acids are now known to
regulate insulin secretion and β-cell integrity via changes
in gene expression, the role of amino acids has, up to
now, been neglected. However, we have recently demon-
strated that key genes in the areas of signal transduction,
metabolism and apoptosis are regulated by alanine or
glutamine (Figure 2). Analysis performed using the
Affymetrix rat genome RGU34A microarray revealed
that a total of 66 genes were increased 1.8-fold or greater
after 24 h culture with l-alanine, and a total of 148 genes
were increased 1.8-fold or greater after 24 h culture with
10 mM l-glutamine. These altered genes are grouped
according to molecular function in Figure 2. Thus,
although the latter two amino acids may acutely regulate
insulin secretion as described below, they also play a
role in regulating β-cell gene expression, which will
impact upon the ability of the β-cell to chronically
respond to nutrient availability, metabolism, insulin se-
cretion and functional integrity.
MECHANISMS OF AMINO-ACID-DEPENDENT
STIMULATION OF INSULIN SECRETION
L-Glutamine
In a recent study, we [9] reported that both rat islets
and BRIN-BD11 β-cells consumed l-glutamine at high
rates. Islets may have a high rate of protein turnover even
underbasalconditions,whichwouldrequirel-glutamine
for purine and pyrimidine synthesis, subsequent mRNA
production and, in addition, protein synthesis. Despite
the fact that l-glutamine is rapidly taken up and
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Figure 2 Gene expression changes in the BRIN-BD11 β-cells
regulated by chronic exposure to L-alanine (upper panel) or
L-glutamine (lower panel)
(Upper panel) Relative sizes of the functional clusters of genes up-regulated at
least 1.8-fold by culture of BRIN-BD11 cells for 24 h with 10 mM L-alanine. The
total number of genes up-regulated 1.8-fold or more was 66. The genes were
grouped as follows: signalling (24%), metabolism (18%), gene regulation (11%),
protein synthesis (9%), structural (3%), stress response (3%), apoptosis (2%),
miscellaneous (3%) and ESTs (expressed sequence tags; 27%). (Lower panel)
Relative sizes of the functional clusters of genes up-regulated at least 1.8-fold by
culture of BRIN-BD11 cells for 24 h with 10 mM L-glutamine. The total number
of genes up-regulated 1.8-fold or more was 148. The genes were grouped as
follows: signal transduction (17%), growth/gene regulation (16%), metabolism
(9%), structural (9%), channels/receptors (7%), apoptosis/inﬂammatory response
(5%), transport (2%), miscellaneous (14%) and ESTs (21%).
metabolized by islets, it alone does not stimulate
insulin secretion or potentiate glucose-induced insulin
secretion [29]. However, it enhances l-leucine-induced
insulin secretion [10]. This action has been attributed
to activation of GDH by l-leucine, which leads to an
increased entry of l-glutamine into the TCA cycle and
subsequent oxidation. Matschinsky and co-workers [30]
have shown that glucose inhibits glutaminolysis in β-
cells and, as a result, blocks leucine-stimulated insulin
secretion (see Figure 3 for details).
It has been reported that l-glutamine is converted
into GABA (γ-aminobutyric acid) in islets [31]. A recent
study[32] has suggested the conversion of glutamine into
GABAasameanstoexplaintheparadoxthatl-glutamine
Figure 3 Schematic diagram describing metabolism of
selected amino acids and the related production of meta-
bolic stimulus–secretion coupling factors involved in insulin
release
αKG, α-ketoglutarate; PDH, pyruvate dehydrogenase; PC, pyruvate carboxy-
lase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AT,
aminotransferase; KIC, α-ketoisocaproic acid; BCKDH, branched chain α-keto-acid
dehydrogenase; GAD, glutamate decarboxylase.
alone does not stimulate insulin release. Fernandez-
Pascual et al. [32] have shown that l-glutamine is
metabolized preferentially to GABA and l-aspartate in
islets and that, in the presence of l-leucine, there is
an increased metabolism of l-glutamate and GABA.
The production of 14CO2 from l-[U-14C]glutamine was
attributed mainly to the formation of GABA, and the
accumulationofl-aspartatewassuggestedtobeasaresult
of oxaloacetate transamination with glutamate where the
oxaloacetate was producedbytheGABAshuntpathway.
Under this scheme there is no oxidation of l-glutamine
via the TCA cycle and the authors suggest [32] that
this may explain the lack of its ability to induce insulin
secretion. GABA released from pancreatic β-cells may
regulate pancreatic α-cell glucagon release via GABAA
receptor occupation, glucagon and glutamate release and
subsequent glutamate receptor (AMPA) activation on β-
cells, as suggested by Moriyama and Hayashi in a recent
review [33].
Using 13C-labelled glutamine and NMR spectroscopy,
we [34] have shown that the major products of l-
[1,213C]glutamine metabolism are l-[1,213C]glutamate
and l-aspartate labelled at positions C1 and C4 in BRIN-
BD11 cells. l-Aspartate is formed after entry of l-
glutamate into the TCA cycle. Additionally, l-glutamate
produced from glutamine entered the γ-glutamyl cycle
and resulted in an increased production of glutathione.
There was no NMR-based evidence for the production
of GABA in our experimental conditions. Addition of
glucose caused an increase in glutamate concentration
but no increase in glutamine consumption, agreeing with
previous reports that glucose can inhibit glutaminolysis.
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Using 13C-isotopomeranalysisofanapleroticﬂuxinINS-
1cells,Clineandco-workers[35]havedemonstratedthat
glutamineadditionincreasedﬂuxthroughGDH,butthis
was not correlated with insulin secretion.
Recently a signalling role for glutamine in insulin
secretion has been proposed [36]. Using normal islets
Li et al. [36] used a potential glutamine synthetase inhi-
bitor MSO (methionine sulphoximine) to investigate
the role of intracellularly generated glutamine in insulin
secretion. They reported that, in the presence of this
inhibitor, the insulin released in response to a glucose
ramp was abolished and that this inhibition could be
reversedbyadditionofl-glutamineoritsnon-metaboliz-
able analogue 6-diazo-5-oxo-l-norleucine. However,
caution should be exercised when interpreting the results
from this study as MSO is not a speciﬁc glutamine
synthetase inhibitor and, indeed, inhibits a number of
glutamate-utilizing enzymes, including γ-glutamylcys-
teine synthetase, thus blocking potential metabolism
of glucose-derived glutamate via the γ-glutamyl cycle.
Although this issue was partially addressed by use
of BSO (buthionine sulphoximine), an inhibitor of
γ-glutamylcysteine synthetase, the mechanisms in-
volved in glutamine-based ‘signalling’ have yet to be
identiﬁed.
L-Glutamate
To date, the role of l-glutamate in the stimulation of
insulin secretion is still controversial. Intracellular gener-
ation of l-glutamate has been proposed to participate
in nutrient-induced stimulus–secretion coupling, as an
additive factor in the amplifying pathway of glucose-
stimulated insulin secretion [37]. During glucose stim-
ulation, total cellular glutamate levels have been reported
to increase in human, mouse and rat islets as well as in
clonal β-cells [8,37–40], whereas, in other studies, no
change was detected [41,42]. The ﬁnding that mito-
chondrial activation in permeabilized β-cells directly
stimulates insulin exocytosis [25] pioneered the identiﬁc-
ation of glutamate as a putative intracellular messenger
[37,43]. Possibly, glutamate could be transported into
secretory granules, thereby promoting Ca2+-dependent
exocytosis [37,43]. Such a model has been substantiated
by the demonstration that clonal β-cells express vesicular
glutamate transporters and that glutamate transport
characteristics are similar to neuronal transporters [44].
The mechanisms by which glutamate promotes insulin
exocytosis might involve pH changes in the secretory
vesicles [45]. In order to challenge the glutamate hy-
pothesis, we [38] overexpressed GAD (glutamate decar-
boxylase)inINS-1Ecellsandratisletstoreducecytosolic
glutamate levels. GAD will catalyse the conversion
of glutamate into GABA, which plays an important
paracrine role in the islet, as described above. In control
cells, glucose (15 mM) caused a 2.3-fold rise in glutamate
Table 1 Consumption of L-alanine and insulin secretion in
response to L-alanine in BRIN-BD11 cells and islets
Consumption of L-alanine is given as µmol·mg−1 of protein·20 min−1. Insulin
secretion is given as ng·106 cells−1 ·20 min−1.D a t af r o m[ 9 ] .
Insulin secretion
L-Alanine Glucose Glucose (1.1 mM)+
Cells (10 mM) consumption (1.1 mM) L-alanine (10 mM)
BRIN-BD11 2.01+ −0.37 1.33+ −0.17 3.83+ −0.18
Islets 7.79+ −2.79 8.67+ −2.00 13.67+ −2.27
concentration, whereas GAD overexpression resulted in
a signiﬁcant reduction in the glutamate response. GAD
overexpression also reduced secretory responses to high
glucose in INS-1E cells as well as rat islets.
Others have robustly challenged the role of glutamate
in insulin secretion [39,42]. MacDonald and Fahien [42]
did not observe an increase in intracellular glutamate
concentration on addition of glucose (16.7 mM) in rat
islets.Incubationwithl-glutamine(10 mM)increasedthe
glutamate concentration 10-fold but did not stimulate
insulin release, leading the authors to cast doubt on
the proposed role of l-glutamate. In a separate study,
Bertrandetal.[39]demonstratedthat,onincubationwith
glucose, a signiﬁcant increase in glutamate concentration
occurred in depolarized mouse and rat islets. However,
they argued against the glutamate hypothesis on the basis
of experiments with l-glutamine: l-glutamine caused an
increase in glutamate content with no effect on insulin
secretion. Additionally in this study, activation of GDH
by BCH (2-amino 2-norbornane carboxylate) lowered
glutamatelevelsbutincreasedinsulinsecretion.However,
l-glutamine as a precursor for glutamate may lead to
saturatingconcentrationsofglutamatewithoutactivation
of the K+
ATP-dependent pathway and thus not result in
an increase in insulin secretion [40].
L-Alanine
l-Alanine is consumed at high rates in both BRIN-BD11
cells and rat islets [9]. Addition of 16.7 mM glucose
signiﬁcantly enhanced l-alanine consumption in both
BRIN-BD11 β-cells and primary islet cells, suggesting a
critical role for l-alanine in β-cell function. Remarkably,
l-alanine consumption by both BRIN-BD11 cells and
primary rat islets was similar to that of d-glucose
(Table 1).
Earlystudieshaveshownthatl-alanineistakenupand
oxidized by ob/ob mouse islets [46]. Recently, l-alanine
has been shown to have insulinotropic effects both in cell
lines and in rat islets [9,14]. Dunne et al. [47] suggested
that in RINm5F cells the insulinotropic action of l-
alaninewasduetoco-transportwithNa+,whichresulted
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in membrane depolarization and led to the generation
of Ca2+ spike potentials and an increase in intracellular
Ca2+.McClenaghan et al.[48],usingthepancreaticβ-cell
lineBRIN-BD11,demonstratedthatl-alanineinﬂuenced
glucose-induced insulin secretion by electrogenic Na+
transport. More recently, l-alanine was shown to be
metabolized by BRIN-BD11 cells using 13CN M R[ 8 ]
to give end-products that included glutamate, aspartate
andlactate.Additionally,byuseoftherespiratorypoison
oligomycin, the metabolism of alanine was shown to be
important for its ability to stimulate insulin secretion [8].
Itisindeedlikelythatacombinationofco-transportwith
Na+ and ATP generation via metabolism results in the
insulinotropic action of this amino acid.
In contrast with our own work, Sener and Malaisse
[49] reported that addition of l-alanine did not stimulate
insulin secretion from rat islet cells. However, in the
presence of l-leucine or 2-ketoisocaproate, alanine pro-
motedinsulinsecretion.Additionally,Sener andMalaisse
[49] showed that l-alanine induced an increase in Ca2+
uptake and was oxidized by the β-cell. They con-
cluded that l-alanine could stimulate insulin secretion
under speciﬁc conditions of nutrient availability and that
the mode of induction of insulin secretion may be a
combination of increased ATP production and Na+ co-
transport.
L-Leucine
l-Leucine stimulates insulin release in pancreatic β-cells
by a process that involves: (i) increased mitochondrial
metabolism by activation of GDH, and (ii) an increase
in ATP production by transamination of leucine to α-
ketoisocaproateandsubsequententryintotheTCAcycle
via acetyl-CoA [10,50,51]. However, leucine-induced
insulin secretion is inhibited in the presence of high
glucose [52], as high glucose inhibits ﬂux through
glutaminase and GDH. There has been renewed interest
in l-leucine metabolism as a result of the observation of
hyperinsulinism in patients with activating mutations in
theregulatorysiteofGDH[53,54].Affectedpatientshave
increased β-cell responsiveness to leucine and develop
hypoglycaemia following a protein meal. Key mutations
in the inhibitory allosteric site in GDH (GTP binding)
result in the loss of negative allosteric regulation.
Although one of the proposed mechanisms by which
l-leucine induces insulin secretion is the conversion
of l-leucine into α-ketoisocaproate, a recent report [55]
has shown that leucine and α-ketoisocaproate stimu-
lated insulin release via distinct mechanisms. α-Ketoiso-
caproate was proposed to stimulate insulin release by a
combination of mechanisms, including its own catabol-
ism and transamination to leucine with production of
α-ketoglutarate.
Previous studies have shown that leucine can activate
the translational regulators PHAS-I (phosphorylated
heat-andacid-stableproteinregulatedbyinsulin)andp70
S6 kinase via mTOR [28,56,57]. Mitochondrial signals
generated by metabolism of leucine have been suggested
tobeimportantfortheactivationofthemTORmitogenic
signalling pathway in the β-cell [58].
L-Arginine
The stimulation of insulin release by l-arginine has been
proposed to involve the transport of the cationic amino
acid into the cell which leads to membrane depolariz-
ation [4,59,60]. A detailed study by Malaisse and co-
workers [61] agreed with this argument. l-Arginine was
shown to cause an elevation in [Ca2+]i as a result of its
electrogenic transport into the β-cell via the amino acid
tranportermCAT2A.Depolarizationoftheplasmamem-
brane will then result in activation of voltage-dependent
Ca2+ channels, an intracellular increase in Ca2+ and
a subsequent stimulation of insulin secretion. Clinical
assessment of administered l-arginine has revealed only
limitedbeneﬁcialeffects,possiblyduetorapidremovalof
theaminoacidintheepithelialcellsoftheintestine,where
it can be rapidly converted into ornithine and citrulline,
then exported to the kidney [62,63] or the liver, and con-
verted into proline for export [63].
Alternatively, l-arginine metabolism in the β-cell can
give rise to glutamate production and thus can inﬂuence
insulin secretion as described above [64]. However, no
studies have yet explored l-arginine metabolism in detail
intheβ-cell,thusthepotentialforl-glutamategeneration
remains to be determined.
ROLE OF AMINO ACIDS IN NADH
MITOCHONDRIAL SHUTTLES
AminoacidsarealsoimplicatedinNADHmitochondrial
shuttle activity, in particular the malate/aspartate shuttle
and its member aralar1 [65]. Aralar1 is an aspartate/
glutamateexchangerisoform,activatedbycytosolicCa2+
and expressed in excitatory tissues, including pancreatic
islets [65–68]. In the course of glucose-stimulated
insulin release, electrons of the glycolysis-derived re-
duced form of NADH are transferred to mitochondria
through the NADH shuttle system. Accordingly, the
NADH shuttle couples glycolysis to activation of mito-
chondrial energy metabolism to trigger insulin secretion.
In β-cells, the NADH shuttle system is composed essen-
tially of the glycerophosphate and the malate/aspartate
shuttles [69]. It was suggested that the malate/aspar-
tate shuttle prevails over the glycerophosphate shuttle
[70] as opposed to other tissues [71].
Inhibition of the malate/aspartate shuttle by amino-
oxyacetate attenuates the secretory response to nutrients
[72].Amino-oxyacetateinhibitstransaminationreactions
and hence will impair the activity of the malate/aspartate
shuttle. Therefore the malate/aspartate shuttle is essential
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for both mitochondrial metabolism and cytosolic redox
state. As evidenced by the lactate/pyruvate ratio [73], the
malate/aspartate shuttle has an important role in nutrient
sensing [74] and glucose-stimulated insulin secretion.
Additionally, the pyruvate/citrate shuttle regenerates
cytosolicNAD+ andmightplayaroleintheformationof
the candidate coupling factor malonyl-CoA in glucose-
induced insulin secretion [75].
Inhibition of cytosolic NADH re-oxidation by mito-
chondria, using amino-oxyacetate, lowers mitochondrial
membrane potential to an extent similar to glucose
deprivation [76] and inhibits insulin secretion [72]. In a
β-cell model with mitochondrial DNA damage, NADH
accumulation decreases mitochondrial membrane poten-
tial and abrogates insulin secretion [77]. Low activity of
NADHshuttlesinβ-cellshasbeenfoundinaging[78,79]
and in models of Type II diabetes [80].
In the mitochondria, the transfer of NADH electrons
to the respiratory chain creates a proton electrochemical
gradient that drives ATP synthesis. The formation of a
proton gradient limits the production of mitochondrial
coupling factors [81]. In addition to ATP generation,
the mitochondrial membrane potential drives the trans-
port of metabolites between mitochondrial and cytosolic
compartments and the production of mitochondrial
factors that couple secretagogue metabolism to insulin
secretion. Therefore the malate/aspartate NADH shuttle
plays a central role in the coupling of glucose recognition
to insulin secretion. In a recent report, we [82] observed
that adenoviral-mediated overexpression of Aralar1 in
insulin-secreting cells increased glucose-induced mito-
chondrial activation and the secretory response. This was
accompaniedbyenhancedglucoseoxidationandreduced
lactate production. Therefore aspartate–glutamate carrier
capacityappearstosetalimitforNADHshuttlefunction
and mitochondrial metabolism.
CONCLUSIONS
Amino acid metabolism is essential to normal pancreatic
β-cellfunction,ashighlightedinthisreview.Acutely,key
amino acids such as alanine and glutamine can regulate β-
cell function and insulin secretion. The mechanisms by
which these amino acids confer their regulatory effects
are complex and involve mitochondrial metabolism.
l-Glutamine metabolism is important for l-glutamate
and glutathione production. d-Glucose conversion into
l-glutamate can occur in speciﬁc conditions of glutamine
limitation, via 2-oxoglutarate in a transamination re-
action. l-Glutamine metabolism appears to be espe-
cially important in the β-cell, due to optimization of
mitochondrial function. Thus l-glutamine is utilized
by the β-cell not only for oxidation, but also for
glutathione production. We speculate that, in conditions
where activation or overexpression of GDH activity is
promoted,themetabolismofl-glutaminewillcontribute
to a rise in the ATP/ADP ratio, thus inactivating the
K+
ATP channel and depolarizing the plasma membrane,
resulting in intracellular Ca2+ elevation and insulin
secretion. Glutamate may play a key role in stimulation
of insulin secretion directly, via metabolism or via
its role in enhancing malate/aspartate shuttle activity.
Other amino acids such as leucine or arginine may
play a role in enhancing insulin secretion by allosteric
activation of metabolism or membrane depolarization
or a combination of these two possibilities. Chronic
effectsofchangesinaminoacidconcentrationinvivoand
invitroonβ-cellfunctionandintegrityhavenotyetbeen
investigatedindetail.Marlissetal.[83]originallyreported
large changes in glutamine and branched-chain amino
acid concentrations (2–10-fold) during progression to
diabetes in the BB Wistar rat (an animal model of dia-
betes). We have determined signiﬁcant changes in plasma
glutamine concentration in newly diagnosed Type I
diabetic patients (A. Kerr, G. Dixon and P. Newsholme,
unpublished work). The effects of the changes in
amino acid concentration on β-cell gene expression
in vivo are unknown, but we have recently determined
speciﬁc functional, signalling and metabolic gene expres-
sion changes in response to l-alanine or l-glutamine
in vitro. Importantly, l-leucine, which is a key regu-
lator of the mTOR signalling pathway (which regulates
protein synthesis via activation of the protein kinase
p70S6K), may play an important role in the maintenance
of β-cell mass in vivo as described by others [84]. Defects
in this pathway result in diminished β-cell size, hypo-
insulinaemia and glucose intolerance as demonstrated in
S6K1-deﬁcientmice[85].Understandingthemechanisms
by which amino acids regulate insulin secretion in vivo
may reveal novel sites for targeting drugs for the therapy
of Type II diabetes in the future.
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